SBRT
Completed
98 enrolled
EARN
Phase NA Completed
33 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
PREFER
Completed
1,429 enrolled
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Phase NA Completed
8 enrolled
IVY
Phase 1 Completed
353 enrolled
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
Phase 4 Completed
337 enrolled 8 charts
SPIRIT
Phase 2 Completed
121 enrolled 12 charts
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.
Phase 2 Completed
37 enrolled 13 charts
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Phase NA Completed
38 enrolled
Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
Phase 2 Completed
730 enrolled 25 charts
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
Phase NA Completed
41 enrolled
ASPIRE
Phase NA Completed
340 enrolled
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Phase 1/2 Completed
49 enrolled
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
DUET-4
Phase 1 Completed
78 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Phase 1/2 Completed
58 enrolled 24 charts
DUET-2
Phase 1 Completed
150 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
VAPOR-C
Phase 4 Completed
169 enrolled
LiPlaCis
Phase 1/2 Completed
50 enrolled
Safety Study of MGA271 in Refractory Cancer
Phase 1 Completed
179 enrolled
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners
Phase NA Completed
14 enrolled
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Phase 1 Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
PSX-X04
Phase 1 Completed
8 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs
Phase NA Completed
20 enrolled
EPAC
Phase NA Completed
213 enrolled 20 charts
CTC
Completed
150 enrolled
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Phase NA Completed
322 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
19 enrolled
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Phase 1 Completed
180 enrolled
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Phase 2 Completed
51 enrolled 6 charts
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Phase 1 Completed
58 enrolled
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155
Phase 2 Completed
10 enrolled
Flavopiridol in Treating Patients With Refractory Cancer
Phase 1 Completed
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Phase 1 Completed
37 enrolled 10 charts
Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1
Phase 1 Completed
23 enrolled
MDX1106-01
Phase 1 Completed
39 enrolled 28 charts
Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer
Phase 1 Completed
30 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
Rapamycin With Grapefruit Juice for Advanced Malignancies
Phase 1 Completed
41 enrolled